Cardiovascular risk factors increase the risk of arterial and venous thrombosis in patients with myeloproliferative neoplasms ...

INCY is likely to beat Q1 earnings estimates, primarily driven by increased U.S. sales and royalties from Novartis on ex-U.S. sales of its lead drug, Jakafi.

Hany Elmariah, MD, discusses how he sees fedratinib fitting into clincal practice for the treatment of myeloproliferative neoplasms.

Incyte’s dermatology business has assumed greater importance for its future growth since its oral Jakafi formulation of ruxolitinib, used to treat myelofibrosis, polycythemia vera, and graft ...

Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis, ...

Di gel get many benefits for dry skin. Aloe vera na incredible plant wit plenty benefits for di body, and e also dey widely used for pharmaceutical and food industries. Hélène Ahonssou ...

Leading up to of PFL’s last part of its First Round of the 2025 World Tournament, fight fans can rack their brains to answer 10 questions related to the organization, its fighters and their ...

Here's the updated 2025 #PFLWorldTournament middleweight bracket: pic.twitter.com/sTMAFHBGAn — Sherdog (@sherdogdotcom) April 19, 2025 The third event of the ...